NHPC Limited submitted its annual disclosure for the centralized database of corporate bonds and debentures for FY 2025-26. The filing includes a comprehensive list of 90 outstanding ISINs as of March 31, 2026, along with their respective allotment and listing details. This is a routine regulatory compliance disclosure under SEBI Master Circular guidelines.
Aayush Wellness Limited has launched 'Liver Detox Tablets' to address the growing demand for preventive liver health solutions in India. The herbal formulation targets lifestyle-related liver disorders and is available on the company's official website. This launch aligns with the company's strategy to expand its condition-led preventive healthcare portfolio in the $18 billion nutraceutical market.
White Oak Capital Management Consultants LLP sold 20,38,948 shares (2.01%) of Rainbow Children's Medicare Ltd. This disposal follows a business transfer and reduces their total holding from 4.81% to 2.80%.
Clean Science and Technology Limited clarified to NSE that the recent increase in trading volume is purely market-driven. The company confirmed there is no undisclosed price-sensitive information or impending corporate actions. It remains in compliance with SEBI (LODR) Regulations regarding timely disclosures.
Nautilus Private Capital Ltd acquired 3,00,000 equity shares (8.5697%) of Lake Shore Realty Ltd (formerly Mahaan Foods Limited) via an open market transaction on April 23, 2026. This acquisition represents a significant stake in the target company by a non-promoter entity.
Promoters of G R Infraprojects Limited executed an inter-se transfer of 88,47,393 equity shares (9.15% stake) via gift. Acquirers include Laxmi Devi Agarwal and others, with shares transferred from various promoter group members. This internal realignment among immediate relatives leaves the aggregate promoter group shareholding unchanged at 74.69%.
Naapbooks Limited submitted its initial disclosure confirming it does not qualify as a 'Large Corporate' under SEBI criteria for the financial year. The company reported outstanding borrowings of ₹0.32 Crore as of March 31, 2026. This is a routine regulatory filing regarding debt-raising framework compliance.
Khaitan Chemicals delivered strong FY26 performance with 39% revenue growth and significant margin expansion, driven by a 10% national SSP market share and robust distribution.
Mukul Agrawal and Param Value Investments acquired 8,62,500 shares (3.958%) of Siyaram Recycling Industries Ltd via the open market for ₹21.79 Crore. This acquisition increases their total holding to 13,37,500 shares (6.138%). The transactions occurred between February 25, 2026, and April 22, 2026.
SCM Commercial Private Limited, a promoter group entity, acquired 74,00,000 equity shares (5.86%) of Deepak Fertilisers & Petrochemicals Corporation Limited via an internal off-market inter-se transfer from Robust Marketing Services Private Limited. The transaction was executed on April 22, 2026, under SEBI SAST exemptions, resulting in no change to aggregate promoter group control.
TAJ GVK Hotels & Resorts Limited announced the release of 56,03,120 pledged shares by promoter group entities Moonshot Trust and Starlight Trust. This release, following partial loan repayment, reduces the total promoter group pledge from 23.73% to 14.80% of the company's share capital.
Robust Marketing Services Private Limited, a promoter group entity of Deepak Fertilisers & Petrochemicals Corporation Limited, sold 74,00,000 (5.86%) equity shares via an off-market inter-se transfer. The transaction took place on April 22, 2026, reducing the seller's stake to 2.91%. This internal restructuring maintains overall promoter group control.
Lalit Dua sold 5,40,000 equity shares (4.76% stake) of Paradeep Parivahan Limited through the open market on April 22, 2026. Following the transaction, the seller's holding in the company reduced to zero. Rajasthan Global Securities Pvt. Ltd. acted as a Person Acting in Concert for this disposal.
Transformers And Rectifiers (India) Limited has issued a postal ballot notice seeking shareholder approval for the re-appointment of Mr. Rajendra S. Shah as an Independent Director. The proposed second term spans five years from May 25, 2026, to May 24, 2031. Voting concludes on April 22, 2026.
Vivek Mundra and associated PACs acquired 2,40,00,000 equity shares (8.10%) of Gayatri Projects Limited via preferential allotment. This acquisition increases their total holding to 10.24%. The transaction was completed on April 22, 2026.
Pari Washington India Master Fund, Ltd. sold 76,817 shares of CARE Ratings Limited through the open market on April 21, 2026. This disposal reduced the combined holding of the fund and its PAC from 7.72% to 7.46% of the company's equity share capital.
Indian Oil Corporation Limited submitted its annual disclosure for the centralized database of corporate bonds and debentures for FY 2025-26. The filing details seven active NCD series listed on NSE and BSE, including listing dates and quantities. This routine SEBI compliance filing provides transparency on the company's outstanding listed debt securities.
T. V. Sandeep Kumar Reddy, promoter of Gayatri Projects Limited, acquired 10,00,00,000 equity shares (21.54%) via preferential allotment on April 22, 2026. This acquisition increases his total holding from 3.94% to 23.13%, strengthening promoter control in the company.
Sundram Fasteners Limited has scheduled a board meeting for April 30, 2026, to consider audited yearly financial results and an interim dividend. The trading window remains closed from March 31, 2026, until May 5, 2026.
Al Maha Investment Fund PCC-ONYX STRATEGY acquired 25,00,000 equity shares in Axentra Corp Limited via preferential allotment. This transaction represents a 12.69% stake in the company. The acquirer is a non-promoter entity, and the acquisition was completed on April 14, 2026.
S D Retail Limited clarified to the NSE that recent significant share price movements are purely market-driven. The company confirmed it has disclosed all material information under Regulation 30 of SEBI Listing Regulations and is unaware of any specific reasons for the price volatility.
Sundram Fasteners Limited has scheduled a Board Meeting on April 30, 2026. The board will review audited standalone and consolidated financial results for FY2026 and consider declaring a second interim dividend. Trading windows for designated persons remain closed until May 5, 2026.
Minerva Ventures Fund acquired 25,00,000 equity shares in Axentra Corp Limited via a preferential allotment. This acquisition represents 12.69% of the target company's total voting capital. Minerva Ventures Fund is classified as a non-promoter acquirer.
Larsen & Toubro has entered the B2B industrial electronics segment with a new business vertical, L&T Electronic Products & Systems (LTEPS). Manufacturing has commenced at its Coimbatore campus with two initial production lines. This strategic expansion aligns with the company's 'Lakshya 2031' goals for technology leadership and self-reliance in critical manufacturing.
DCM Limited promoters Mr. Yuv Bharat Ram and Mr. Rahil Bharat Ram propose to acquire 6,30,000 shares each (6.74% total stake) via an inter-se gift from their father, Mr. Sumant Bharat Ram. This internal promoter group consolidation involves no cash consideration and maintains aggregate promoter control.
BF Utilities Ltd clarified to BSE that recent increases in share price and trading volume are purely market-driven. The company confirmed it has disclosed all price-sensitive information under SEBI Regulation 30 and remains in compliance with listing requirements.
BF Utilities Limited clarified to the NSE that the recent increase in share trading volume is purely market-driven. The company confirmed it has made all necessary disclosures under SEBI Regulations and is not aware of any undisclosed price-sensitive information impacting its stock movement.
Dr. Reddy's clarified a news report regarding its Semaglutide Injection. The company confirmed it is awaiting 'Notice of Compliance' from Health Canada but has received 'Drug Identification Numbers' as of April 22, 2026. Management stated there is no material impact on the company from the news article.
Dr. Reddy's Laboratories clarified a news report regarding its Semaglutide Injection. The company confirmed it has not yet received a 'Notice of Compliance' from Health Canada but did receive 'Drug Identification Numbers' (DINs) on April 22, 2026. The company continues to engage with regulatory authorities for Canadian market approval.
Dr. Reddy's Laboratories clarified news reports regarding its Semaglutide Injection. The company confirmed it is still awaiting 'Notice of Compliance' from Health Canada, though it received Drug Identification Numbers on April 22, 2026. Management remains engaged with regulatory authorities to bring the product to the Canadian market.